PPG Industries Valuation

Is 0KEI undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 0KEI when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 0KEI ($123.94) is trading below our estimate of fair value ($178.13)

Significantly Below Fair Value: 0KEI is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 0KEI?

Key metric: As 0KEI is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 0KEI. This is calculated by dividing 0KEI's market cap by their current earnings.
What is 0KEI's PE Ratio?
PE Ratio19.2x
EarningsUS$1.49b
Market CapUS$28.39b

Price to Earnings Ratio vs Peers

How does 0KEI's PE Ratio compare to its peers?

The above table shows the PE ratio for 0KEI vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average25.2x
CRDA Croda International
29.7x15.1%UK£4.8b
JMAT Johnson Matthey
24x28.4%UK£2.6b
VCT Victrex
24.4x37.8%UK£749.6m
TET Treatt
22.7x15.3%UK£256.6m
0KEI PPG Industries
19.2x7.8%US$28.4b

Price-To-Earnings vs Peers: 0KEI is good value based on its Price-To-Earnings Ratio (19.2x) compared to the peer average (25.2x).


Price to Earnings Ratio vs Industry

How does 0KEI's PE Ratio compare vs other companies in the European Chemicals Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
0KEI 19.2xIndustry Avg. 17.1xNo. of Companies11PE01224364860+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 0KEI is expensive based on its Price-To-Earnings Ratio (19.2x) compared to the European Chemicals industry average (17.9x).


Price to Earnings Ratio vs Fair Ratio

What is 0KEI's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

0KEI PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio19.2x
Fair PE Ratio17.7x

Price-To-Earnings vs Fair Ratio: 0KEI is expensive based on its Price-To-Earnings Ratio (19.2x) compared to the estimated Fair Price-To-Earnings Ratio (17.7x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 0KEI forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$123.76
US$147.46
+19.2%
7.4%US$166.00US$120.00n/a24
Nov ’25US$124.79
US$147.46
+18.2%
7.4%US$166.00US$120.00n/a24
Oct ’25US$130.62
US$149.88
+14.7%
6.6%US$166.00US$118.00n/a24
Sep ’25US$128.72
US$149.92
+16.5%
6.8%US$166.00US$118.00n/a23
Aug ’25US$125.98
US$149.92
+19.0%
6.8%US$166.00US$118.00n/a23
Jul ’25US$124.22
US$155.71
+25.4%
7.0%US$175.00US$118.00n/a23
Jun ’25US$130.55
US$156.32
+19.7%
6.9%US$175.00US$118.00n/a23
May ’25US$130.92
US$156.50
+19.5%
6.7%US$175.00US$118.00n/a24
Apr ’25US$145.28
US$157.47
+8.4%
7.5%US$175.00US$117.00n/a23
Mar ’25US$140.25
US$158.43
+13.0%
7.8%US$175.00US$117.00n/a23
Feb ’25US$141.11
US$158.99
+12.7%
7.6%US$175.00US$117.00n/a24
Jan ’25US$150.01
US$154.89
+3.3%
8.5%US$174.00US$117.00n/a22
Dec ’24US$143.24
US$153.39
+7.1%
7.8%US$170.00US$117.00n/a22
Nov ’24US$122.24
US$153.11
+25.3%
7.3%US$166.00US$117.00US$124.7923
Oct ’24US$130.77
US$160.19
+22.5%
8.1%US$180.00US$115.00US$130.6223
Sep ’24US$141.47
US$159.35
+12.6%
8.4%US$180.00US$115.00US$128.7224
Aug ’24US$145.74
US$158.25
+8.6%
8.8%US$180.00US$115.00US$125.9825
Jul ’24US$148.48
US$151.76
+2.2%
8.1%US$169.00US$114.00US$124.2225
Jun ’24US$134.11
US$151.38
+12.9%
8.2%US$169.00US$114.00US$130.5524
May ’24US$140.56
US$150.18
+6.8%
8.3%US$169.00US$114.00US$130.9222
Apr ’24US$131.88
US$138.26
+4.8%
9.4%US$159.00US$112.00US$145.2823
Mar ’24US$134.16
US$138.33
+3.1%
9.2%US$159.00US$112.00US$140.2524
Feb ’24US$130.73
US$138.33
+5.8%
9.2%US$159.00US$112.00US$141.1124
Jan ’24US$124.96
US$131.26
+5.0%
10.8%US$155.00US$104.00US$150.0123
Dec ’23US$134.38
US$127.96
-4.8%
10.6%US$154.00US$104.00US$143.2423
Nov ’23US$112.99
US$127.96
+13.2%
10.6%US$154.00US$104.00US$122.2423

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies